Senior Lecturer,
City St George's, University of London
host : (N. Bonnefoy, IRCM)
selected publications :
Bacevic K*, Noble R*, Soffar A, Ammar OW, Boszonyik B, Prieto S, Vincent C, Hochberg ME, Krasinska L, Fisher D. Spatial competition constrains resistance to targeted cancer therapy. Nature Communications (2017) 8, 1995
Viossat Y, Noble R. A theoretical analysis of tumour containment. Nature Ecology & Evolution (2021)
Patil S, Viossat Y, Noble R. Preventing evolutionary rescue in cancer. bioRxiv (2023)
Physiological Sciences Department, Faculty of Science, Stellenbosch University, South Africa.
Resia Pretorius is a Distinguished Professor at Stellenbosch University (South Africa), Honorary Professor at the University of Liverpool, and founding director of Biocode Technologies. Her research focuses on how inflammation disrupts coagulation and immune function, leading to microclots, platelet activation, and endothelial pathology across diseases including cancer, diabetes, cardiovascular disease and Long COVID. She has published over 330 papers, filed multiple patents on microclot diagnostics, and serves on global health advisory panels including the WHO.
host : Alain R. Thierry (IRCM)
https://orcid.org/0000-0001-8857-2609
Department of Translational Research and New Technologies in Medicine, University of Pisa, Italy.
hôte : Andrei TURTOI (IRCM)
Université Libre de Bruxelles
host : Laurent Le Cam (IRCM)
Situé dans le Parc Euromédecine, l'Institut de Recherche en Cancérologie de Montpellier (U1194) est localisé sur le Campus Val d'Aurelle (ICM, Institut régional du Cancer Montpellier / Val d'Aurelle).
Centre de Recherche U1194 soutenu par l'Inserm, l'Université de Montpellier et l'Institut du Cancer de Montpellier (ICM)
Institut de Recherche en Cancérologie de
